Healthcare in England generates 24.9 million tonnes of carbon dioxide equivalents (COe), equating to approximately 4% of the total national output of greenhouse gases (GHG), and of this, 10% is from the manufacturing of medical equipment. Operating theatres are a major contributor of biomedical waste, especially consumables, and are three-to-six times more energy intensive than the rest of the hospital. This study seeks to quantify and evaluate the carbon cost, or footprint, of neurosurgery at a single institution in England. A single neurosurgical operation generates, on average, 8.91 kg of waste per case, equivalent to 24.5 COe kg per case, mostly from single-use equipment. Per annum, 1300 neurosurgical operative cases are performed with total waste generation of 11,584.4 kg/year and a carbon footprint of 31,859 (kg) COe. The challenge of achieving net zero GHG presents an opportunity to catalyse innovation and sustainability in neurosurgery, from how care is delivered, through to equipment use and surgical methodologies. This should improve the quality of healthcare provision to patients and yield potential cost savings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141268 | PMC |
http://dx.doi.org/10.3390/ijerph19105995 | DOI Listing |
Biomedicines
November 2024
Department of Neurosurgery, Brown University, Rhode Island Hospital, Providence, RI 02903, USA.
: Schwann cells (SCs) and their plasticity contribute to the peripheral nervous system's capacity for nerve regeneration after injury. The promoter antisense RNA (Egr2-AS) recruits chromatin remodeling complexes to inhibit transcription following peripheral nerve injury. : RNA-seq and ATAC-seq were performed on control cells, Lenti-GFP-transduced cells, and cells overexpressing Egr2-AS (Lenti-AS).
View Article and Find Full Text PDFJ Biomed Opt
February 2025
University of Texas Medical Branch, Department of Neurosurgery, Galveston, Texas, United States.
Significance: Accurate identification between pathologic (e.g., tumors) and healthy brain tissue is a critical need in neurosurgery.
View Article and Find Full Text PDFAdv Exp Med Biol
November 2024
Department of Neurosurgery, University Hospital of Münster, Münster, Germany.
Malignant glioma resection is often the first line of treatment in neuro-oncology. During glioma surgery, the discrimination of tumor's edges can be challenging at the infiltration zone, even by using surgical adjuncts such as fluorescence guidance (e.g.
View Article and Find Full Text PDFRadiother Oncol
January 2025
Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Br J Neurosurg
October 2024
Department of Neurosurgery, North Bristol Trust, Bristol, UK.
Background: The climate crisis is one of the greatest threats to public health and surgery is a significant contributor to carbon emissions generated by the NHS. In this paper, we describe our experience of sustainable operating by using evidence-based methods to reduce our carbon footprint across three neurosurgical theatres during our 'Green operating day'.
Methods: The Green operating day was run at a single site over a 12-hour operative day and included 10 neurosurgical cases.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!